Biotech

All Articles

Ultragenyx fine-tunes gene therapy dosing to call up effectiveness

.A minority of patients taking Ultragenyx Drug's Wilson condition genetics therapy UX701 have come o...

Biopharma discharge rate supports in Q3: Intense Biotech study

.As summer warm looks to cool winds, hopes that this year would certainly carry wide-spread market a...

J &amp J falls stage 2 dengue candidate in latest change from vaccines

.Johnson &amp Johnson's deprioritization of its contagious disease pipeline has stated one more prey...

Relay loses 10% of team after earlier cutbacks in July

.Precision medication biotech Relay Rehabs is actually shedding around 10% of its workforce in initi...

Pentixapharm scores $22M IPO to advance radiopharma tests

.Pentixapharm has actually generated nearly 20 million euros ($ 22 million) coming from an IPO, with...

Lundbeck touches Charles River for AI-enabled neuro medication invention

.Lundbeck has actually tapped Charles River Laboratories' artificial intelligence capabilities to as...

Big pharma, biotech 'won't necessarily be symbiotic' in artificial intelligence: S&ampP

.Big Pharma is committing greatly in artificial intelligence to slash advancement timelines and fost...

I &amp I biotech Triveni raises $115M for preclinical antibodies

.Triveni Biography has actually trapped $115 thousand in series B funds to advance preclinical antib...

IGM pivots from cancer cells to autoimmune, shocking C-suite

.IGM Biosciences ended last year laying off staff and also streamlining its cancer pipe. Right now, ...

Shattuck centers CD47 course over weak efficiency data, gives up 40% of staff and loses Ono handle

.Shattuck Labs has actually pounded one more nail right into the casket of CD47. After finding a "sm...